Lifecore Biomedical, Inc.

NASDAQ

Market Cap.

307.31M

Avg. Volume

229.02K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Lifecore Biomedical, Inc.

Lifecore Biomedical, Inc. News

Lifecore Biomedical, Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock
Website screenshot
HealthcareDrug Manufacturers - Specialty & Generic
lifecore.com

About Lifecore Biomedical, Inc.

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was incorporated in 1986 and is headquartered in Santa Maria, California.

Lifecore Biomedical, Inc. Earnings & Revenue

What’s This Company Really Worth? Find Out Instantly.

Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.

Lifecore Biomedical, Inc. Financials

Table Compare

Compare LFCR metrics with:

   

Earnings & Growth

LFCR

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

LFCR

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

LFCR

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

LFCR

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Lifecore Biomedical, Inc. Income

Lifecore Biomedical, Inc. Balance Sheet

Lifecore Biomedical, Inc. Cash Flow

Lifecore Biomedical, Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Sell
Return on EquityStrong Sell
Return on AssetsStrong Sell
Debt/Equity RatioStrong Sell
Price/Earnings RatioStrong Sell
Price/Book RatioStrong Sell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Lifecore Biomedical, Inc. Executives

NameRole
Dr. Albert D. Bolles Ph.D.President of Curation Foods, Inc.
Mr. James G. HallAdvisor
Mr. Parker K. JavidVice President
Mr. Paul JosephsPresident, Chief Executive Officer & Director
Mr. Aaron PerlitshDirector of Internal Audit & Chief Compliance Officer
NameRoleGenderDate of BirthPay
Dr. Albert D. Bolles Ph.D.President of Curation Foods, Inc.19581.34M
Mr. James G. HallAdvisorMale1963642.75K
Mr. Parker K. JavidVice PresidentMale1969321.91K
Mr. Paul JosephsPresident, Chief Executive Officer & DirectorMale1966135.56K
Mr. Aaron PerlitshDirector of Internal Audit & Chief Compliance OfficerMale

--

Lifecore Biomedical, Inc. Insider Trades

Date8 Jul
NameSalus Thomas D.
RoleChief Legal & Administration
TransactionAcquired
TypeM-Exempt
Shares37000
Date8 Jul
NameSalus Thomas D.
RoleChief Legal & Administration
TransactionDisposed
TypeF-InKind
Shares11022
Date8 Jul
NameSalus Thomas D.
RoleChief Legal & Administration
TransactionDisposed
TypeM-Exempt
Shares37000
Date8 Jul
NameLake Ryan David
RoleChief Financial Officer
TransactionAcquired
TypeM-Exempt
Shares75000
Date8 Jul
NameLake Ryan David
RoleChief Financial Officer
TransactionDisposed
TypeF-InKind
Shares32806
DateNameRoleTransactionTypeShares
8 JulSalus Thomas D.Chief Legal & AdministrationAcquiredM-Exempt37000
8 JulSalus Thomas D.Chief Legal & AdministrationDisposedF-InKind11022
8 JulSalus Thomas D.Chief Legal & AdministrationDisposedM-Exempt37000
8 JulLake Ryan DavidChief Financial OfficerAcquiredM-Exempt75000
8 JulLake Ryan DavidChief Financial OfficerDisposedF-InKind32806

Discover More

Streamlined Academy

Lifecore Biomedical, Inc.

NASDAQ

Market Cap.

307.31M

Avg. Volume

229.02K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Lifecore Biomedical, Inc. News

Lifecore Biomedical, Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock

Lifecore Biomedical, Inc. Earnings & Revenue

Lifecore Biomedical, Inc. Income

Lifecore Biomedical, Inc. Balance Sheet

Lifecore Biomedical, Inc. Cash Flow

Lifecore Biomedical, Inc. Financials Over Time

Lifecore Biomedical, Inc. Executives

NameRole
Dr. Albert D. Bolles Ph.D.President of Curation Foods, Inc.
Mr. James G. HallAdvisor
Mr. Parker K. JavidVice President
Mr. Paul JosephsPresident, Chief Executive Officer & Director
Mr. Aaron PerlitshDirector of Internal Audit & Chief Compliance Officer
NameRoleGenderDate of BirthPay
Dr. Albert D. Bolles Ph.D.President of Curation Foods, Inc.19581.34M
Mr. James G. HallAdvisorMale1963642.75K
Mr. Parker K. JavidVice PresidentMale1969321.91K
Mr. Paul JosephsPresident, Chief Executive Officer & DirectorMale1966135.56K
Mr. Aaron PerlitshDirector of Internal Audit & Chief Compliance OfficerMale

--

Lifecore Biomedical, Inc. Insider Trades

Date8 Jul
NameSalus Thomas D.
RoleChief Legal & Administration
TransactionAcquired
TypeM-Exempt
Shares37000
Date8 Jul
NameSalus Thomas D.
RoleChief Legal & Administration
TransactionDisposed
TypeF-InKind
Shares11022
Date8 Jul
NameSalus Thomas D.
RoleChief Legal & Administration
TransactionDisposed
TypeM-Exempt
Shares37000
Date8 Jul
NameLake Ryan David
RoleChief Financial Officer
TransactionAcquired
TypeM-Exempt
Shares75000
Date8 Jul
NameLake Ryan David
RoleChief Financial Officer
TransactionDisposed
TypeF-InKind
Shares32806
DateNameRoleTransactionTypeShares
8 JulSalus Thomas D.Chief Legal & AdministrationAcquiredM-Exempt37000
8 JulSalus Thomas D.Chief Legal & AdministrationDisposedF-InKind11022
8 JulSalus Thomas D.Chief Legal & AdministrationDisposedM-Exempt37000
8 JulLake Ryan DavidChief Financial OfficerAcquiredM-Exempt75000
8 JulLake Ryan DavidChief Financial OfficerDisposedF-InKind32806

Streamlined Academy

Website screenshot
HealthcareDrug Manufacturers - Specialty & Generic
lifecore.com

About Lifecore Biomedical, Inc.

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was incorporated in 1986 and is headquartered in Santa Maria, California.

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Lifecore Biomedical, Inc.

What’s This Company Really Worth? Find Out Instantly.

Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.

Lifecore Biomedical, Inc. Financials

Table Compare

Compare LFCR metrics with:

   

Earnings & Growth

LFCR

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

LFCR

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

LFCR

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

LFCR

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Sell
Return on EquityStrong Sell
Return on AssetsStrong Sell
Debt/Equity RatioStrong Sell
Price/Earnings RatioStrong Sell
Price/Book RatioStrong Sell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More

The Secret to Analyzing Winning Stocks (Step-by-Step Examples Inside)